JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 37
Type: Contributed
Date/Time: Sunday, July 29, 2012 : 2:00 PM to 3:50 PM
Sponsor: Business and Economic Statistics Section
Abstract - #304959
Title: Cost-Effectiveness Comparison of Whole Breast Irradiation, Brachytherapy, and No Radiation Treatment in Elderly Patients with Breast Cancer
Author(s): Jing Jiang*+ and Jinhai Huo and Hui Zhao and Weiguo He and Benjamin D. Smith
Companies: MD Anderson Cancer Center and MD Anderson Cancer Center and The University of Texas School of Public Health and The University of Texas School of Public Health and MD Anderson Cancer Center
Address: Department of Biostatistics, Houston, TX, 77030, United States
Keywords: cost-effectiveness ; seer medicare ; propensity score ; radiation therapy ; subsequent mastectomy ; breast cancer

We identified 41,683 patients aged 66 years and older from the SEER Medicare database that had been diagnosed with breast cancer between 2001 to 2007 and treated with lumpectomy followed by whole breast irradiation (WBI) or brachytherapy (BT) or no radiation treatment (NRT). The cost data for each patient were calculated by adding Medicare claims from 2000 to 2009. The benefit was the 5-year subsequent mastectomy survival rate which was calculated from the Kaplan-Meier statistical method. Cost-effectiveness was estimated using a propensity-score net monetary benefits value approach. The 5-year occurrence rate of mastectomy was lowest in patients treated with WBI (1.31% vs. 3.19 % in BT, P< 0.001, and 1.31% vs. 4.04% in NRT, p< 0.001). BT was dominated by WBI. The incremental cost-effectiveness of WBI versus NRT was $20,980 per mastectomy prevented, or $23,947 after being adjusted for propensity score. In this study, we determined the effectiveness and cost-effectiveness of WBI and BT versus NRT in a large population-based patient sample. The use of WBI as primary radiation therapy to prevent mastectomy may be cost-effective, depending on willingness to pay.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.